| Literature DB >> 35955986 |
Changyu Huang1, Yang Chen1, Haiqi Ding1, Zida Huang1, Chaofan Zhang1, Wenbo Li1, Xi Liu2, Zhanhai Tu2, Wenming Zhang1, Xinyu Fang1.
Abstract
The diagnosis and treatment of periprosthetic joint infection (PJI) is complex and the use of MRI in PJI is gaining attention from orthopedic surgeons as MR technology continues to advance. This study aimed to investigate whether metal artefact reduction sequence (MARS) MRI could be used as an adjunct in the preoperative diagnosis of PJI and to explore its role in PJI debridement planning. From January 2020 to November 2021, participants with metal joint prostheses that needed to be judged for infection were prospectively enrolled. According to Musculoskeletal Infection Society standards, 31 cases were classified as infection, and 20 as non-infection. The sensitivity and specificity of MARS MRI for the diagnosis of PJI were 80.65% and 75%, respectively. In MARS MRI, the incidence of bone destruction, lamellar synovitis, and extracapsular soft tissue oedema were significantly higher in PJI than in non-PJI. Fourteen suspicious occult lesions were found in the preoperative MARS MRI in 9 cases, and the location of 9 infection lesions was confirmed intraoperatively. In conclusion, MARS MRI is an effective diagnostic tool for PJIand can provide a visual reference for preoperative surgical planning.Entities:
Keywords: MRI; diagnosis; metal artifact reduction sequences; periprosthetic joint infection
Year: 2022 PMID: 35955986 PMCID: PMC9369276 DOI: 10.3390/jcm11154371
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Flow chart of two-stage exchange arthroplasty and inclusion of cases. PJI: periprosthetic joint infection.
Figure 2Typical case 1. Male, 41 years old, right total hip arthroplasty. (A): MARS MRI before stage I resection surgery; (B): X-ray before stage I resection surgery; (C): MARS MRI before stage II reimplantation; (D): X-ray before stage II reimplantation, the arrow shows bone cement spacer containing metal; (E,F): X-ray after stage II reimplantation.
Protocol of metal artifact reduction sequence.
| TE (ms) | TR (ms) | TI (ms) | FOV (mm) | NEX | RBW (kHZ) | ST (mm) | Matrix | VAT | Flip Angle (Degrees) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hip | T1w tse Tra | 7.7 | 620 | 360 × 360 | 1 | 625 | 4 | 320 × 192 | On | 144 | |
| PD tirm Cor | 36 | 4160 | 220 | 340 × 340 | 2 | 601 | 4 | 320 × 256 | On | 138 | |
| PD tirm Tra | 36 | 3500 | 220 | 360 × 270 | 2 | 601 | 4 | 320 × 256 | On | 137 | |
| Knee | T1w tse Sag | 8.7 | 420 | 180 × 180 | 1 | 625 | 4 | 320 × 224 | On | 137 | |
| PD tirm Sag | 33 | 5380 | 220 | 180 × 180 | 2 | 601 | 4 | 320 × 192 | On | 138 | |
| PD tirm Cor | 33 | 5380 | 220 | 180 × 180 | 2 | 601 | 4 | 320 × 192 | On | 138 | |
| PD tirm Tra | 33 | 3500 | 220 | 200 × 162 | 2 | 601 | 4 | 320 × 256 | On | 137 |
TE: Echo time, TR: Repetition time, TI: Inversion time, FOV: Field of view, NEX: Number of excitations, RBW: Receiver bandwidth, ST: Slice thickness, VAT: View-angle tilting.
Figure 3MARS characteristic performance on PJI. (A): sinus; (B): bone edema; (C): extracapsular collections; (D): lamellated synovitis; (E): intracapsular collections; (F): bone destruction: arrow at the lesser trochanter; extracapsular soft-tissue edema: juxtaposed arrow.
Microbiology finding of culture.
| PJI, | Non-PJI, | |||
|---|---|---|---|---|
| Mono-Pathogen, | Multi-Pathogen, | CN PJI, | Aseptic Loosening, | Stage II Reimplantation Surgery, |
PJI: Prosthetic joint infection, CN PJI: Culture-negative prosthetic joint infection.
Characteristics of cases.
| Characteristic | All Cases | PJI | Non-PJI | ||
|---|---|---|---|---|---|
| Female ( | 34 | 18 | 16 | 0.105 a | |
| Age (yrs) | 60.569 ± 12.400 | 60.774 ± 13.266 | 60.250 ± 11.252 | 0.885 b | |
| Joint involved ( | 0.891 a | ||||
| hip | 30 | 18 | 12 | ||
| knee | 21 | 13 | 8 | ||
| CRP (mg/L), median, IQR | 11.020 (4.210, 27.260) | 19.29 (11.100, 69.300) | 4.380 (2.120, 5.823) | <0.001 c | |
| ESR (mm/h), | 47.800 ± 33.829 | 64.650 ± 33.602 | 28.700 ± 17.147 | <0.001 b | |
| SF-WBC (×106/L), median, IQR | 2623.000 (795.000, 8024.000) | 6185.000 (2623.000, 35,883.000) | 672.000 (278.250, 1110.750) | <0.001 c | |
| SF-PMN% (%), median, IQR | 66.600 (45.200, 83.900) | 81.900 (66.900, 88.100) | 45.200 (39.025, 51.225) | <0.001 c | |
a Chi-squared, b Independent-samples t-test, c Mann-Whitney U test; PJI: Prosthetic joint infection, SF-WBC: Synovial fluid white blood cell, SF-PMN: Synovial fluid polymorphonuclear, IQR: Interquartile range, CRP: C-reactive protein, ESR: Erythrocyte sedimentation rate.
Statistical analysis of diagnostic efficiency of each characteristic of MARS MRI in PJI.
| Variable | PJI | Non-PJI | Sensitivity | Specificity | Youden’s Index | PPV | NPV | LR+ | LR− | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sinus | 4/31 | 0/20 | 0.145 | 12.90% | 100% | 0.129 | 100% | 42.55% | N/A | 0.871 |
| Bone destruction | 17/31 | 5/20 | 0.046 | 54.84% | 75% | 0.298 | 77.27% | 51.72% | 2.194 | 0.602 |
| Bone edema | 23/31 | 10/20 | 0.132 | 74.19% | 50% | 0.242 | 69.70% | 55.56% | 1.484 | 0.516 |
| Lamellated synovitis | 20/31 | 5/20 | 0.009 | 64.52% | 75% | 0.395 | 80.00% | 57.69% | 2.581 | 0.473 |
| Extracapsular edema | 28/31 | 7/20 | <0.001 | 90.32% | 65% | 0.7 | 80.00% | 81.25% | 2.581 | 0.149 |
| Intracapsular collections | 24/31 | 14/20 | 0.743 | 77.42% | 30% | 0.074 | 63.16% | 46.15% | 1.106 | 0.753 |
| Extracapsular collections | 11/31 | 5/20 | 0.543 | 35.48% | 75% | 0.105 | 68.75% | 42.86% | 1.419 | 0.860 |
a Fisher’s exact test; Youden’ s index = sensitivity + specificity − 1; PJI: Prosthetic joint infection, LR+: Positive likelihood ratio, LR−: Negative likelihood ratio, NPV: Negative predictive value, PPV: Positive predictive value, N/A: Not applicable.
Statistical analysis of diagnostic efficiency of each index of MSIS and MARS MRI in PJI.
| Variable | PJI | Non-PJI | Sensitivity | Specificity | Youden’s Index | PPV | NPV | LR+ | LR− | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MARS MRI | 25/31 | 5/20 | 80.65% | N/A | 75% | N/A | 0.556 | 83.33% | 71.43% | 3.226 | 0.258 |
| Culture | 23/31 | 5/20 | 74.19% | 0.727 | 75% | 1.000 | 0.642 | 92% | 69.23% | 7.419 | 0.287 |
| Pre-OP culture | 10/31 | 3/20 | 32.26% | 0.001 | 85% | 0.625 | 0.173 | 76.92% | 44.74% | 2.151 | 0.797 |
| Intra-OP culture | 21/31 | 2/20 | 67.74% | 0.344 | 90% | 0.453 | 0.577 | 91.30% | 64.29% | 6.774 | 0.358 |
| CRP (>10 mg/L) | 26/31 | 2/20 | 83.87% | 1.000 | 90% | 0.375 | 0.739 | 92.86% | 78.26% | 8.387 | 0.179 |
| ESR (>30 mm/h) | 25/31 | 8/20 | 80.65% | 1.000 | 60% | 0.180 | 0.406 | 75.76% | 66.67% | 2.016 | 0.323 |
| SF-WBC (>3000 × 106/L) | 23/31 | 1/20 | 74.19% | 0.687 | 95% | 0.125 | 0.692 | 95.83% | 70.37% | 14.84 | 0.272 |
| SF-PMN% (>80%) | 19/31 | 0/20 | 61.30% | 0.109 | 100% | N/A | 0.613 | 100% | 62.50% | N/A | 0.387 |
| Bone destruction+ Lamellated synovitis | 26/31 | 7/20 | 83.87% | - | 65% | - | 0.489 | 78.79% | 72.22% | 2.396 | 0.248 |
| Bone destruction+ Extracapsular edema | 28/31 | 9/20 | 90.32% | - | 55% | - | 0.453 | 75.68% | 78.57% | 2.007 | 0.176 |
| Lamellated synovitis+ Extracapsular edema | 29/31 | 10/20 | 93.55% | - | 50% | - | 0.435 | 74.36% | 83.33% | 1.871 | 0.129 |
a McNemar’s test; Youden’ s index = sensitivity + specificity − 1; MARS: Metal artifact reduction sequence, PJI: Prosthetic joint infection, LR+: Positive likelihood ratio, LR−: Negative likelihood ratio, NPV: Negative predictive value, PPV: Positive predictive value, N/A: Not applicable, SF-WBC: Synovial fluid white blood cell, SF-PMN: Synovial fluid polymorphonuclear, OP: operative.
Figure 4Typical case 2. Female, 68 years old, left total hip arthroplasty. (A,B): X-ray before stage I resection surgery; (C): MARS MRI showed signs of acetabular bone destruction and bone edema (at the arrow); (D): intraoperative exploration revealed occult lesions in the acetabulum; (E): histopathology of the acetabulum suggests infection; (F): X-ray after stage I resection surgery.